4.7 Article

Discovery of ellagic acid as a competitive inhibitor of Src homology phosphotyrosyl phosphatase 2 (SHP2) for cancer treatment: In vitro and in silico study

Journal

Publisher

ELSEVIER
DOI: 10.1016/j.ijbiomac.2023.127845

Keywords

SHP2 inhibitor; Ellagic acid; Anticancer activity

Ask authors/readers for more resources

This study discovered that ellagic acid is a competitive inhibitor of SHP2 with high inhibitory activity. It also demonstrated the inhibitory effects of ellagic acid on cancer cell proliferation and the synergistic effect when combined with a KRASG12C inhibitor. Furthermore, the study revealed the mechanism of ellagic acid's action through molecular docking and dynamics.
Targeting SHP2 has become a potential cancer treatment strategy. In this study, ellagic acid was first reported as a competitive inhibitor of SHP2, with an IC50 value of 0.69 +/- 0.07 itM, and its inhibitory potency was 34.86 times higher that of the positive control NSC87877. Ellagic acid also had high inhibitory activity on the SHP2E76K and SHP2-E76A mutants, with the IC50 values of 1.55 +/- 0.17 itM and 0.39 +/- 0.05 itM, respectively. Besides, the IC50 values of ellagic acid on homologous proteins SHP1, PTP1B, and TCPTP were 0.93 +/- 0.08 itM, 2.04 +/- 0.28 itM, and 11.79 +/- 0.83 itM, with selectivity of 1.35, 2.96, and 17.09 times, respectively. The CCK8 proliferation experiment exhibited that ellagic acid would inhibit the proliferation of various cancer cells. It was worth noting that the combination of ellagic acid and KRASG12C inhibitor AMG510 would produce a strong synergistic effect in inhibiting NCI-H358 cells. Western blot experiment exhibited that ellagic acid would downregulate the phosphorylation levels of Erk and Akt in NCI-H358 and MDA-MB-468 cells. Molecular docking and molecular dynamics studies revealed the binding information between SHP2 and ellagic acid. In summary, this study provides new ideas for the development of SHP2 inhibitors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available